GHK-CU

Addresses the decline in structural integrity and regenerative capacity in skin and tissue models by targeting collagen-associated signaling and oxidative stress.

$120.00

Best Sellers

Review Third-Party Certificates of Analysis:

COA

Core Analytical Specifications:

Chemical Purity Assay

Net Mass Verification

Microbial Sterility Screening

Endotoxin (LPS) Detection

Verified
Purity
Thresholds

Independent
COA
Validation

Secure
Trackable
Shipping

Synthesized, Analytically Verified, and Dispatched from United States.

Molecular Design & Functional Mechanism

GHK-Cu is a copper-bound tripeptide complex investigated for its role in tissue remodeling, including collagen-associated signaling, angiogenesis-related pathways, and antioxidant enzyme modulation in skin and repair models. 

What Research Shows 

  • Regenerative/ECM signaling: Research summaries describe stimulation of collagen-associated processes and repair phenotypes in wound/skin contexts. 
  • Clinical-facing interest: Public-facing reporting highlights its prominence in skin-aging discussions, anchored to earlier clinical observations around collagen-related outcomes (interpret cautiously; cosmetic literature varies in rigor). 

Why Research Teams Choose Us

  • ECM + inflammation + oxidative stress convergence: Supports multi-endpoint repair panels (collagen markers, angiogenesis proxies, antioxidant activity).
  • Strong topical/dermal research footprint: Useful when labs need a well-known comparator in skin and tissue remodeling experiments.
Molecular Design & Functional Mechanism

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. Foundation Plus supplies compounds intended for laboratory research and development purposes. Products are not promoted for consumer, medical, or veterinary use. These products are not drugs, food additives, or dietary supplements and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Related Products

Leave a review

Compliance & Age Verification

Access to the Foundation Plus digital storefront is strictly restricted to individuals 21 years of age or older.

The compounds available on this site are intended solely for laboratory research purposes. These materials are not designed to prevent, treat, or cure any medical condition and are strictly not for human consumption. By entering this site, you verify that you meet the age requirement, acknowledge these clinical restrictions, and possess a legitimate research basis for the procurement of these products.

Please note that all compounds are provided as individual units.

I am under 21 / Exit